[1] |
Döffinger R, Helbert MR, Barcenas-Morales G, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis, 2004, 38(1):e10-4. doi:10.1086/380453.
pmid: 14679469
|
[2] |
Tang BS, Chan JF, Chen M, et al. Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon. Clin Vaccine Immunol, 2010, 17(7):1132-1138. doi:10.1128/CVI.00053-10.
|
[3] |
Kerner G, Rosain J, Guérin A,et al. Inherited human IFN-γ deficiency underlies mycobacterial disease. J Clin Invest, 2020, 130(6):3158-3171. doi:10.1172/JCI135460.
pmid: 32163377
|
[4] |
Yang R, Mele F, Worley L,et al. Human T-bet governs innate and innate-like adaptive IFN-gamma immunity against Mycobacteria. Cell, 2020, 183(7):1826-1847. doi:10.1016/j.cell.2020.10.046.
pmid: 33296702
|
[5] |
Qiu Y, Tang M, Zeng W,et al. Clinical findings and predictive factors for positive anti-interferon-γ autoantibodies in patients suffering from a non-tuberculosis mycobacteria or Talaromyces marneffei infection:a multicenter prospective cohort study. Sci Rep, 2022, 12(1):9069. doi:10.1038/s41598-022-13160-x.
pmid: 35641599
|
[6] |
Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficicency in Thailand and Taiwan. N Engl J Med, 2012, 367(8):725-734. doi:10.1056/NEJMoa1111160.
|
[7] |
Liang S, Liang H, Huang X,et al. Clinical immunological characteristics of anti-interferon-γ autoantibodies syndrome: a 3 year prospective cohort study. Emerg Microbes Infect, 2024, 13(1):2396887. doi:10.1080/22221751.2024.2396887.
|
[8] |
田园, 荆玮, 王庆枫,等. 抗γ干扰素自身抗体阳性耐多药结核病并发马尔尼菲等多重感染一例并文献复习. 中国防痨杂志, 2024, 46(11):1335-1342. doi:10.19982/j.issn.1000-6621.20240212.
|
[9] |
Kiratikanon S, Phinyo P, Rujiwetpongstorn R, et al. Adul-tonset immunodeficiency duetoanti-interferon-gammaautoanti-body-associated Sweet syndrome: A distinctive entity. J Dermatol, 2022, 49(1):133-141. doi:10.1111/1346-8138.16202.
|
[10] |
Su HA, Chen HA, Wang SH,et al. Generalized Pustular Eruptionina Patient with Adult-Onset Immunodeficiency Due to Anti-Interferon-Gamma Autoantibodies. Ann Dermatol, 2023, 35(Suppl 2):S350-S351. doi:10.5021/ad.21.111.
|
[11] |
Hidekawa C, Yoshimi R, Kishimoto D,et al. Anti-interferongamma antibody-seropositive disseminated Nontuberculous mycobacterial infection mimicking POEMS and TAFRO syndromes. Intern Med, 2022, 61(15):2377-2385. doi:10.2169/internalmedicine.8366-21.
|
[12] |
聂永都, 潘思琪, 王瀚,等. 抗干扰素γ自身抗体介导的成人起病免疫缺陷症13例分析. 中华结核和呼吸杂志, 2023, 46(2):144-150. doi:10.3760/cma.j.cn1121147-202220725-00625.
|
[13] |
Zeng W, Tang M, Yang M,et al. Intravenous cyclophosphamide therapy for anti-IFN-gamma autoantibody-associated Talaromyces marneffei infection. Open Forum Infect Dis, 2022, 9(12):c612. doi:10.1093/ofid/ofac612.
|
[14] |
Lee WI, Fang YF, Huang JL,et al. Distinct lymphocyte immunophenotyping and quantitative anti-interferon gamma autoantibodies in Taiwanese of China HIV-negative patients with Non-tuberculous mycobacterial infections. J Clin Immunol, 2023, 43(4):717-727. doi:10.1007/s10875-022-01423-1.
|
[15] |
Tham EH, Huang CH, Soh JY, et al. Neutralizing anti interferon gamma autoantibody levels may not correlate with clinical course of disease. Clin Infect Dis, 2016, 63(4):572-573. doi:10.1093/cid/ciw351.
|